Login / Signup
All anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes.
Bruce Anthony Campbell Cree
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Keyphrases
</>
human health
nk cells
risk assessment
climate change